课题基金 / 基金详情

CONSORTIUM FOR THE LONGITUDINAL EVALUATION OF AFRICAN AMERICANS WITH EA (CLEAR)

CONSORTIUM FOR THE LONGITUDINAL EVALUATION OF AFRICAN AMERICANS WITH EA (CLEAR)
与 EA 一起对非裔美国人进行纵向评估的联盟(CLEAR)
批准号:
7380405
负责人:
LARRY W MORELAND
金额:
$1.57万
依托单位国家:
美国
项目类别:
财政年份:
2006
资助国家:
美国
项目状态:
已结题
起止时间:
2006-03-01 至 2007-02-28

项目摘要

项目成果

LARRY W MORELAND的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. The purpose of this study is to create a registry of African Americans with early rheumatoid arthritis. This is the first early rheumatoid arthritis registry in which a large cohort of African Americans is systematically studied in a longitudinal fashion. The registry will include a total of 500 patients who will be evaluable at 5 years disease duration. To obtain the goal of 500, as many as 600 patients will be enrolled. One of the primary aims of the registry is to isolate and immortalize genomic DNA from patient blood samples for use in future studies. The Pittman GCRC processes, stores, and isolates all genomic DNA obtained through this registry. The GCRC Informatics Core serves as the database repository using Teleform and other data management capabilities to manage the registry data. A total of 9 patients were enrolled in the reporting period, during which exemption status was pending from the OMB.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
UPITT Rheumatoid Arthritis Combined Center (UPITT RACC)
ANTIBODIES AND MARKERS OF DISEASE ACTIVITY IN PATIENTS WITH AUTOIMMUNE DISEASES
Rheumatoid Arthritis Induction Trial (RAITMAT)
AUTOIMMUNE BIOMARKERS COLLABORATIVE NETWORK
海外基金